| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |